Press release
Peroxisome Proliferator Activated Receptor Delta - Products under Development by Top 10 Indications, H1 2018
Peroxisome Proliferator
Overview
Peroxisome Proliferator-Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator-Activated Receptor Beta or NR1C2 or PPARD) - Peroxisome proliferator-activated receptor delta is a nuclear receptor that in humans is encoded by the PPARD gene.
PPAR-delta is a nuclear hormone receptor that governs a variety of biological processes and involved in the development of several chronic diseases, including diabetes, obesity, atherosclerosis, and cancer.
The expression of this gene is found to be elevated in colorectal cancer cells. The elevated expression can be repressed by adenomatosis polyposis coli (APC), a tumor suppressor protein involved in the APC/beta-catenin signaling pathway.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811474-peroxisome-proliferator-activated-receptor-delta-nuci-or-nuclear-hormone-receptor
Top Companies mentioned
CymaBay Therapeutics Inc
Genfit SA
Inventiva
Mitobridge Inc
Nippon Chemiphar Co Ltd
Senju Pharmaceutical Co Ltd
T3D Therapeutics Inc
Peroxisome Proliferator Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Peroxisome Proliferator - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Peroxisome Proliferator , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are 3, 3, 3 and 5 respectively.
Peroxisome Proliferator pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Peroxisome Proliferator - Competitive Analysis
Key players are making innovative developments in Peroxisome Proliferator industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Peroxisome Proliferator.
The pipeline guide reviews pipeline therapeutics for Peroxisome Proliferator by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Peroxisome Proliferator therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Peroxisome Proliferator therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Peroxisome Proliferator.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2811474-peroxisome-proliferator-activated-receptor-delta-nuci-or-nuclear-hormone-receptor
Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peroxisome Proliferator Activated Receptor Delta - Products under Development by Top 10 Indications, H1 2018 here
News-ID: 949678 • Views: …
More Releases from WiseGuy Research consultants Pvt Ltd.
Beauty Drinks Market and its Future Outlook and Trend During the Period of 2019 …
Global Beauty Drinks Market Research Report 2019
Summary: -
Wiseguyreports.Com Adds “Beauty Drinks - Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2025” To Its Research Database.
Overview:
Beauty drinks refer to both carbonated and non-carbonated beverages, which is used to retain natural beauty during aging. The beauty drinks contain various vitamins, minerals, amino acids, and antioxidants. It aids to support diets by encouraging metabolism. The global beauty drinks market…
Global Capsule Endoscopy Treatment Solutions Market 2020: key Vendors, Trends, A …
Summary
A New Market Study, titled “Capsule Endoscopy Treatment Solutions Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.
This report provides in depth study of “Capsule Endoscopy Treatment Solutions Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Capsule Endoscopy Treatment Solutions Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such…
Data Center Colocation Market 2019: Size, Share, Demand, Trends, Growth and 2025 …
Global Data Center Colocation Industry
New Study On “2019-2025 Data Center Colocation Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database
Data center operators face an increasing need for scalable data center infrastructure, which enables the scaling of critical data center components as and when the demand increases. The data center colocation provides data center space, along with the power and cooling infrastructure, which address…
Temperature Logger Market 2019 Trends, Research, Analysis & Review Forecast 2025
Global Temperature Logger Industry
New Study On “2019-2025 Temperature Logger Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database
This report studies the global Temperature Logger market status and forecast, categorizes the global Temperature Logger market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The…
More Releases for Peroxisome
Peroxisome Proliferator Activated Receptor Delta Market Is Set to Boom in 2021 A …
A consistent market research report like Peroxisome Proliferator Activated Receptor Delta Market report extends reach to the success in the business. All the data and statistic included in the report is backed up by well-known analysis tools which include SWOT analysis and Porter’s Five Forces analysis. Market research studies carried out in this report are very considerate which assist businesses to take better decisions and develop superior strategies about production,…
Peroxisome Proliferator Market 2020 Clinical Analysis to 2026
Peroxisome Proliferator-Activated Receptor (PPAR) Agonist -Pipeline Insight, 2020
The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Peroxisome Proliferator Market on the basis of stating current situation of the industry in 2020.
This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life…
Liver Fibrosis Treatment Market Rapid Growth By Leading Players Gilead Sciences, …
Increasing number of clinical trials by key players focused on development of an efficient treatment option for liver fibrosis is expected to drive the growth of the liver fibrosis treatment market in near future. In October 2010, FibroGen, Inc. initiated phase II clinical study of FG-3019: a human monoclonal antibody against the Connective Tissue Growth Factor (CTGF) to compare the efficacy in reversing the effects of liver fibrosis caused by…
Global Peroxisome Proliferator Activated Receptor Delta Market Prediction 2018-2 …
The Market research report studies the global Peroxisome Proliferator Activated Receptor Delta market status and forecast, categorizes the global Peroxisome Proliferator Activated Receptor Delta market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa).
Global Major Players Analysis such as Chipscreen Biosciences…
Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Recept …
ReportsWorldwide has announced the addition of a new report title Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group…
Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Recept …
Market Research Hub (MRH) added a new research report to its vast database titled “Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) Pipeline Review, H2 2017” targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It…
